Brucine Entrapped Titanium Oxide Nanoparticle for Anticancer Treatment: An In Vitro Study
Backgroundand Objective. The public’s health has been seriously threatened by cervical cancer during recent times. In terms of newly diagnosed cases worldwide, it ranks as the ninth most prevalent malignancy. Multiple investigations have proven that nanoparticles can effectively combat cancer due to...
Päätekijä: | Rashed M. Almuqbil |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Wiley
2024-01-01
|
Sarja: | Advances in Pharmacological and Pharmaceutical Sciences |
Linkit: | http://dx.doi.org/10.1155/2024/4646855 |
Samankaltaisia teoksia
-
A Combination of In Silico ADMET Prediction, In Vivo Toxicity Evaluation, and Potential Mechanism Exploration of Brucine and Brucine N-oxide—A Comparative Study
Tekijä: Yan Gao, et al.
Julkaistu: (2023-01-01) -
Graphene oxide/chitosan/manganese/folic acid-brucine functionalized nanocomposites show anticancer activity against liver cancer cells
Tekijä: Alzahrani Abdullah R., et al.
Julkaistu: (2024-07-01) -
Synthesis and Characterization of Graphene Oxide/Polyethylene Glycol/Folic Acid/Brucine Nanocomposites and Their Anticancer Activity on HepG2 Cells
Tekijä: Ibrahim IAA, et al.
Julkaistu: (2024-02-01) -
Analysis of Brucine using Poly(L-Arginine) modified biosynthesized CuO nanoparticle composite sensor
Tekijä: Sumanth Devaraj, et al.
Julkaistu: (2024-12-01) -
Quality by Design for Development, Optimization and Characterization of Brucine Ethosomal Gel for Skin Cancer Delivery
Tekijä: Tamer A. Ismail, et al.
Julkaistu: (2021-06-01)